VIJAYA
Vijaya Diagnostic Centre Limited
Diagnostic services provider with radiology and pathology testing facilities
Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider
vijayadiagnostic.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Vijaya Diagnostic Centre runs diagnostic centres that sell imaging (radiology) and pathology tests, mainly to individual patients rather than to businesses, with its largest base in Hyderabad.
Company snapshot
2ndBy market cap
Ranked among 10 companies in Healthcare Service Provider.
What we see
- ✓Net margin of 21.2% — the business keeps a healthy share of every rupee it earns.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 139 Cr | 133 Cr | 155 Cr | 156 Cr | 183 Cr | 169 Cr | 173 Cr | 188 Cr | 202 Cr | 205 Cr | 219 Cr | 231 Cr |
| Operating expenses (approx.) | 81 Cr | 80 Cr | 92 Cr | 95 Cr | 107 Cr | 102 Cr | 104 Cr | 115 Cr | 120 Cr | 119 Cr | 124 Cr | 132 Cr |
| EBITDA | 57 Cr | 52 Cr | 63 Cr | 61 Cr | 76 Cr | 67 Cr | 69 Cr | 74 Cr | 82 Cr | 86 Cr | 96 Cr | 99 Cr |
| OPM % | 41.3% | 39.4% | 40.7% | 39.2% | 41.5% | 39.7% | 39.8% | 39.1% | 40.6% | 41.9% | 43.5% | 42.7% |
| Other income | 7 Cr | 5 Cr | 3 Cr | 4 Cr | 5 Cr | 5 Cr | 6 Cr | 7 Cr | 6 Cr | 5 Cr | 2 Cr | 9 Cr |
| Interest | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 6 Cr | 7 Cr | 7 Cr | 7 Cr | 8 Cr | 9 Cr | 9 Cr | 11 Cr |
| Depreciation | 14 Cr | 15 Cr | 16 Cr | 17 Cr | 17 Cr | 18 Cr | 19 Cr | 21 Cr | 22 Cr | 24 Cr | 24 Cr | 25 Cr |
| Profit before tax | 45 Cr | 35 Cr | 44 Cr | 42 Cr | 57 Cr | 47 Cr | 47 Cr | 52 Cr | 58 Cr | 58 Cr | 64 Cr | 71 Cr |
| Tax % | 24.7% | 25.2% | 23.2% | 24.8% | 26.3% | 24.4% | 26.4% | 26.1% | 25.4% | 25.8% | 25.4% | 25.2% |
| Net profit | 34 Cr | 26 Cr | 34 Cr | 32 Cr | 42 Cr | 35 Cr | 35 Cr | 39 Cr | 43 Cr | 43 Cr | 48 Cr | 53 Cr |
| EPS (₹) | ₹3.26 | ₹2.53 | ₹3.27 | ₹3.06 | ₹4.09 | ₹3.42 | ₹3.38 | ₹3.76 | ₹4.21 | ₹4.20 | ₹4.66 | ₹5.16 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 293 Cr | 339 Cr | 377 Cr | 462 Cr | 459 Cr | 548 Cr | 681 Cr | 814 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 184 Cr | 206 Cr | 211 Cr | 259 Cr | 277 Cr | 327 Cr | 408 Cr | 477 Cr | Sign in free for the trailing twelve months |
| EBITDA | 108 Cr | 133 Cr | 166 Cr | 204 Cr | 182 Cr | 221 Cr | 273 Cr | 337 Cr | Sign in free for the trailing twelve months |
| OPM % | 37.0% | 39.1% | 44.1% | 44.1% | 39.6% | 40.3% | 40.1% | 41.4% | Sign in free for the trailing twelve months |
| Other income | 10 Cr | 15 Cr | 12 Cr | 13 Cr | 14 Cr | 21 Cr | 18 Cr | 21 Cr | Sign in free for the trailing twelve months |
| Interest | 14 Cr | 15 Cr | 15 Cr | 16 Cr | 21 Cr | 24 Cr | 27 Cr | 33 Cr | Sign in free for the trailing twelve months |
| Depreciation | 40 Cr | 49 Cr | 50 Cr | 53 Cr | 62 Cr | 57 Cr | 71 Cr | 92 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 65 Cr | 83 Cr | 112 Cr | 147 Cr | 114 Cr | 159 Cr | 193 Cr | 233 Cr | Sign in free for the trailing twelve months |
| Tax % | 29.2% | 25.1% | 24.3% | 24.9% | 24.9% | 24.6% | 25.6% | 25.7% | Sign in free for the trailing twelve months |
| Net profit | 46 Cr | 63 Cr | 85 Cr | 111 Cr | 85 Cr | 120 Cr | 144 Cr | 173 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹4.50 | ₹6.13 | ₹8.26 | ₹10.76 | ₹8.29 | ₹11.62 | ₹13.95 | ₹16.81 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | 0.0% | 12.0% | 8.5% | 7.1% | 11.9% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 5 Cr | 5 Cr | 5 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr |
| Reserves | 203 Cr | 270 Cr | 354 Cr | 458 Cr | 535 Cr | 647 Cr | 785 Cr | 947 Cr |
| Borrowings | 42 Cr | 33 Cr | 4 Cr | 0.63 Cr | — | — | — | — |
| Other liabilities | 157 Cr | 175 Cr | 177 Cr | 243 Cr | 307 Cr | 323 Cr | 474 Cr | 550 Cr |
| Total liabilities | 406 Cr | 482 Cr | 541 Cr | 713 Cr | 853 Cr | 983 Cr | 1,274 Cr | 1,507 Cr |
| Fixed assets (net) | 144 Cr | 140 Cr | 136 Cr | 364 Cr | 294 Cr | 602 Cr | 724 Cr | 930 Cr |
| CWIP | 3 Cr | 9 Cr | 8 Cr | 34 Cr | 249 Cr | 8 Cr | 70 Cr | 34 Cr |
| Investments | 69 Cr | 55 Cr | 28 Cr | 54 Cr | 139 Cr | 109 Cr | 185 Cr | 228 Cr |
| Inventories | 2 Cr | 3 Cr | 3 Cr | 4 Cr | 2 Cr | 5 Cr | 5 Cr | 5 Cr |
| Trade receivables | 9 Cr | 8 Cr | 6 Cr | 10 Cr | 9 Cr | 16 Cr | 15 Cr | 21 Cr |
| Cash & bank | 10 Cr | 56 Cr | 7 Cr | 11 Cr | 24 Cr | 22 Cr | 13 Cr | 40 Cr |
| Other assets | 170 Cr | 212 Cr | 354 Cr | 236 Cr | 135 Cr | 220 Cr | 263 Cr | 249 Cr |
| Total assets | 406 Cr | 482 Cr | 541 Cr | 713 Cr | 853 Cr | 983 Cr | 1,274 Cr | 1,507 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 91 Cr | 106 Cr | 130 Cr | 158 Cr | 165 Cr | 183 Cr | 224 Cr | 271 Cr |
| Cash from investing | -90 Cr | -31 Cr | -130 Cr | -123 Cr | -110 Cr | -142 Cr | -182 Cr | -174 Cr |
| Cash from financing | -7 Cr | -30 Cr | -49 Cr | -31 Cr | -42 Cr | -45 Cr | -52 Cr | -69 Cr |
| Net cash flow | -6 Cr | 46 Cr | -49 Cr | 4 Cr | 13 Cr | -4 Cr | -9 Cr | 27 Cr |
| Free cash flow (OCF − Capex) | 31 Cr | 69 Cr | 98 Cr | 36 Cr | 40 Cr | 95 Cr | 129 Cr | 88 Cr |
Ratios
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 31.6% | 32.2% | 35.0% | 34.8% | 24.6% | 27.7% | 27.5% | 27.8% |
| ROE % | 22.2% | 22.8% | 23.5% | 23.4% | 15.5% | 18.0% | 17.9% | 18.1% |
| Debtor days | 11 | 9 | 6 | 8 | 8 | 11 | 8 | 9 |
| Inventory days | 20 | 23 | 17 | 22 | 13 | 29 | 21 | 19 |
| Days payable | 196 | 180 | 141 | 110 | 171 | 184 | 142 | 144 |
| Cash conversion cycle | -165 | -149 | -118 | -81 | -151 | -144 | -113 | -116 |
| OCF / EBITDA % | 83.7% | 80.0% | 78.1% | 77.6% | 90.4% | 83.0% | 82.2% | 80.3% |
| OCF / EBITDA % (3 years) | — | — | 80.2% | 78.4% | 82.0% | 83.4% | 84.7% | 81.6% |
| Debt / equity | 0.20 | 0.12 | 0.01 | 0.0014 | — | — | 0.00 | 0.00 |
| Current ratio | — | — | — | 4.08 | 4.17 | 2.90 | 1.89 | 2.60 |
| Net debt / EBITDA | 0.30 | -0.17 | -0.01 | -0.05 | -0.13 | -0.10 | -0.05 | -0.12 |